Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
BioFlyte
AddedFeb 15, 2024
UpdatedJun 18, 2026
BioFlyte

BioFlyte

Series B

BioFlyte provides innovative aerosol mass spectrometers for protection against biological and chemical threats.

HQ
Albuquerque, NM, US
Founded
2020
Overview
Compare
Fundraising
Employees
Website

Founded with the mission to safeguard critical infrastructure and public health, BioFlyte specializes in innovative aerosol mass spectrometers designed to detect and identify biological and low-volatility chemical threats at the point of need. Their products are engineered to be both affordable and scalable, eliminating the dependency on expensive reagents and consumables. BioFlyte focuses on providing security solutions for various market segments, including public safety, military, and industrial sectors.

BioFlyte has attracted notable investors and industry experts who support its mission to revolutionize biothreat detection. The company has achieved significant milestones in developing fieldable technology that offers rapid, on-site threat identification. Its impact is evident in enhanced security measures for critical infrastructure and improved response times for biological threat detection, positioning BioFlyte as a key player in the biothreat security industry.

BioFlyte - Similar Companies

Zeteo Tech logo

Zeteo Tech

zeteotech.com

Trace Matters logo

Trace Matters

tracematters.com

Aerosol Devices logo

Aerosol Devices

aerosoldevices.com

Evogen logo

Evogen

evogen.com

Biota Technology logo

Biota Technology

biota.com

BioLum Sciences logo

BioLum Sciences

biolumsciences.com

Andson Biotech logo

Andson Biotech

andsonbiotech.com

Innovative Biosensors logo

Innovative Biosensors

The Public Health Company logo

The Public Health Company

BennuBio logo

BennuBio

bennubio.com

Adeptrix logo

Adeptrix

adeptrix.com

Thermo Fisher th logo

Thermo Fisher th

thermofisher.com

Biomeme logo

Biomeme

bio-meme.com

Stemloop logo

Stemloop

stemloop.com

Fluent BioSciences logo

Fluent BioSciences

fluentbio.com

BioFlyte - Quick Facts

Who are BioFlyte's competitors?

Companies similar to BioFlyte include Zeteo Tech, Trace Matters, Aerosol Devices and Evogen.

When was BioFlyte founded?

BioFlyte was founded in 2020.

Where is BioFlyte's headquarters located?

BioFlyte's headquarters is located in Albuquerque, NM, US.

When was BioFlyte's last funding round?

BioFlyte's most recent funding round was for $5.4M (USD) in August 2023.

How much has BioFlyte raised to-date?

As of Aug 10, 2023, BioFlyte has raised a total of $12.8M (USD).

How many employees does BioFlyte have?

BioFlyte has 39 employees as of Feb 5, 2024.

BioFlyte - Classification

Industry
  • Hardware
Ownership
  • Venture Capital
Technology
  • Analytics
Geographic Exposure
  • Global
Revenue
  • Recurring
  • Transactional
Customer
  • Enterprise
  • Government
Main Product
  • Mass Spectrometers
Tags
  • Biotech
  • Security
NAICS
  • 320000Manufacturing
  • 325000Chemical Manufacturing
SIC
  • 2890Miscellaneous Chemical Products
  • 2899Chemicals And Chemical Preparations, Not Elsewhere Classified
  • 2800Chemicals And Allied Products